Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v3.10.0.1
Debt (Tables)
6 Months Ended
Jun. 30, 2018
Debt Disclosure [Abstract]  
Summary of Lines of Credit
The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings at June 30, 2018
 
Credit line
capacity
 
June 30,
2018
 
December 31,
2017
JPMorgan Chase
 
4.01%
 
$
175,000

 
$
105,539

 
$
104,152

Itau Bank
 
5.50%
 
1,810

 
1,179

 
446

Bank of Chile
 
6.60%
 
3,800

 
502

 
1,598

BICE Bank
 
5.50%
 
2,500

 
798

 
1,819

BBVA Bank
 
5.50%
 
3,250

 
250

 
1,665

Security Bank
 
5.50%
 
98

 
98

 
501

Estado Bank
 
5.50%
 
3,500

 
757

 
2,111

Santander Bank
 
5.50%
 
4,500

 
262

 
1,988

Scotiabank
 
5.00%
 
1,800

 
9

 
384

Banco Bilbao Vizcaya
 
2.90%
 
292

 

 

Santander Bank
 
2.67%
 
350

 
102

 

Total
 
 
 
$
196,900

 
$
109,496

 
$
114,664

Schedule of Debt
The following table sets forth information related to the 2033 Senior Notes which is included in our Condensed Consolidated Balance Sheets as of December 31, 2017 and June 30, 2018:
(In thousands)
2033 Senior Notes
 
Discount
 
Debt Issuance Cost
 
Total
Balance at December 31, 2017
$
31,850

 
$
(2,565
)
 
$
(125
)
 
$
29,160

Amortization of debt discount and debt issuance costs

 
1,109

 
74

 
1,183

Balance at June 30, 2018
$
31,850

 
$
(1,456
)
 
$
(51
)
 
$
30,343

At June 30, 2018 and December 31, 2017, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the Credit Agreement and amounts outstanding under lines of credit) as follows:
(In thousands)
June 30,
2018
 
December 31,
2017
Current portion of notes payable
$
2,821

 
$
1,632

Other long-term liabilities
6,469

 
2,011

Total
$
9,290

 
$
3,643